ANIP - Company ID 0001023024
The table below shows ANI PHARMACEUTICALS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $285.58M | $144.86M | $221.12M | $48.23M | $100.30M | $7.86M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $281.08M | $221.73M | $162.08M | $165.44M | $128.53M | $95.79M |
| Inventory | $143.07M | $136.78M | $111.20M | $105.36M | $81.69M | $60.80M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $753.12M |
| $527.68M |
| $519.82M |
| $344.26M |
| $321.77M |
| $170.32M |
| Property, plant & equipment | $62.48M | $56.86M | $44.59M | $43.25M | $52.67M | $41.27M |
| Goodwill | $62.48M | $59.99M | $28.22M | $28.22M | $27.89M | $3.58M |
| Total assets | $1.44B | $1.28B | $904.42M | $760.09M | $771.60M | $461.19M |
| Accounts payable | $62.58M | $45.66M | $36.68M | $29.30M | $22.97M | $11.26M |
| Total current liabilities | $278.11M | $193.68M | $145.48M | $99.44M | $87.54M | $78.56M |
| Long-term debt | $291.84M | $309.11M | $284.82M | $285.67M | $286.52M | $172.44M |
| Total liabilities | $899.65M | $855.17M | $446.82M | $421.55M | $412.86M | $265.49M |
| Retained earnings | -$23.10M | -$100.28M | -$80.13M | -$97.29M | -$47.77M | -$4.97M |
| Total equity | $540.72M | $403.68M | $432.75M | $313.69M | $333.89M | $195.70M |